DMRJ knows much more than is public, that's why they are relaxing(somewhat) the financing and allowing Implant to concentrate on getting the product developed. Still a longshot, but a good longshot..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.